Protara Therapeutics Inc. (NASDAQ: TARA)
$2.40
+0.0200 ( +0.84% ) 227.6K
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Market Data
Open
$2.40
Previous close
$2.38
Volume
227.6K
Market cap
$49.42M
Day range
$2.28 - $2.61
52 week range
$1.04 - $5.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 5 | Apr 26, 2024 |
8-k | 8K-related | 63 | Apr 05, 2024 |
8-k | 8K-related | 14 | Mar 18, 2024 |
8-k | 8K-related | 16 | Mar 13, 2024 |
10-k | Annual reports | 96 | Mar 13, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |